Potassium canrenoate explained
Potassium canrenoate (INN, JAN) or canrenoate potassium (USAN) (brand names Venactone, Soldactone), also known as aldadiene kalium,[1] the potassium salt of canrenoic acid, is an aldosterone antagonist of the spirolactone group.[2] Like spironolactone, it is a prodrug, and is metabolized to active canrenone in the body.[3] [4]
Potassium canrenoate is notable in that it is the only clinically used antimineralocorticoid which is available for parenteral administration (specifically intravenous)[5] as opposed to oral administration.[6]
In the UK, it is unlicensed and only used for short term diuresis in oedema or heart failure in neonates or children under specialist initiation and monitoring.
See also
Notes and References
- Book: Selye H . Hormones and Resistance: Part 1 and. 17 April 2013. Springer Science & Business Media. 978-3-642-65192-2. 186–.
- Book: Hill RA, Makin HL, Kirk DN, Murphy GM . Dictionary of Steroids. 23 May 1991. CRC Press. 978-0-412-27060-4. 656–.
- Book: Burger A, Wolff ME . Burger's Medicinal Chemistry and Drug Discovery: Therapeutic agents. 1996. Wiley. 978-0-471-57557-3.
- Book: Waldmann C, Soni N, Rhodes A . Diurectics and the Critical Ill . Oxford Desk Reference: Critical Care. https://books.google.com/books?id=eLqMpXfAlEcC&pg=PA187. 27 November 2008. OUP Oxford. 978-0-19-922958-1. 187–.
- Book: Santambrogio R, Barabino M, Opocher E . Non-resection: Radiofrequency Ablation, Cryo, Microwave . Bonjer HJ . Surgical Principles of Minimally Invasive Procedures: Manual of the European Association of Endoscopic Surgery (EAES). https://books.google.com/books?id=tAImDwAAQBAJ&pg=PA136. 21 June 2017. Springer. 978-3-319-43196-3. 136–.
- Kolkhof P, Bärfacker L . 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development . The Journal of Endocrinology . 234 . 1 . T125–T140 . July 2017 . 28634268 . 5488394 . 10.1530/JOE-16-0600 .